Gender | Age category (years) | |||||
---|---|---|---|---|---|---|
Antimalarial drugs | Female n (%) | Male n (%) | Under 5 n (%) | 5 – 12 n (%) | 13 – 18 n (%) | 19 and above n (%) |
Artemisinin-based combination therapy (ACT) | 1127 (93) | 881(94) | 182(85) | 45 (87) | 101(97) | 1286 (95) |
Artemether-lumefantrin (AL) | 568 (50) | 446 (51) | 128 (70) | 31 (69) | 50 (50) | 624 (49) |
Artesunate-amodiaquine (ASAQ) | 113 (10) | 125 (14) | 29 (16) | 3 (7) | 15 (15) | 184 (14) |
Artesunate-mefloquine (ASMF) | 168 (15) | 64 (7) | - | - | 5 (5) | 113 (9) |
Artesunate-sulphadoxine + pyrimethamine (ASSP) | 115 (10) | 72 (8) | 18 (10) | 11 (24) | 9 (9) | 82 (6) |
Dihydroartemisinin-piperaquine (DHAPQ) | 163 (14) | 174 (20) | 7 (4) | - | 22 (22) | 283 (22) |
Monotherapy | 80(7) | 61(6) | 32(15) | 7 (13) | 3 (3) | 70 (5) |
Sulphadoxine + pyrimethamine (SP) | 39 (49) | 28 (44) | 4 (13) | 2 (29) | 2 (67) | 44 (63) |
Artesunate (AS) | 23 (29) | 17 (27) | 11 (34) | 1 (14) | 1 (33) | 19 (27) |
Amodiaquine (AQ) | 7 (9) | 6 (9) | 12 (38) | 1 (14) | - | - |
Quinine (QN) | 2 (3) | 4 (6) | - | 1(14) | - | 5 (7) |
Proguanil (PG) | 9(11) | 6(14) | 5 (16) | 2 (29) | - | 2 (3) |
Co-medication | ||||||
Analgesics | 920 (76) | 783 (83) | 119 (59) | 34 (54) | 87 (84) | 1148 (85) |
Vitamin preparations | 701 (56) | 646 (69) | 106 (52) | 35 (56) | 69 (66) | 951 (70) |
Antibiotics | 569 (47) | 502 (53) | 115 (57) | 23 (37) | 59 (57) | 720 (53) |